Financial results - DR. ILEANA DUMITRACHE S.R.L.

Financial Summary - Dr. Ileana Dumitrache S.r.l.
Unique identification code: 35533081
Registration number: J38/77/2016
Nace: 8622
Sales - Ron
120.636
Net Profit - Ron
80.063
Employee
5
The most important financial indicators for the company Dr. Ileana Dumitrache S.r.l. - Unique Identification Number 35533081: sales in 2023 was 120.636 euro, registering a net profit of 80.063 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dr. Ileana Dumitrache S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 20.554 49.170 61.160 73.157 83.910 87.007 96.409 120.636
Total Income - EUR - - 20.558 49.171 61.160 73.613 83.911 87.007 96.410 120.637
Total Expenses - EUR - - 13.038 28.206 31.300 46.311 31.578 37.613 34.031 39.548
Gross Profit/Loss - EUR - - 7.520 20.965 29.860 27.302 52.333 49.394 62.379 81.089
Net Profit/Loss - EUR - - 7.303 20.473 29.249 26.566 51.549 48.541 61.531 80.063
Employees - - 2 3 4 5 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 25.5%, from 96.409 euro in the year 2022, to 120.636 euro in 2023. The Net Profit increased by 18.719 euro, from 61.531 euro in 2022, to 80.063 in the last year.

Check the financial reports for the company - Dr. Ileana Dumitrache S.r.l.

Rating financiar

Financial Rating -
Dr. Ileana Dumitrache S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dr. Ileana Dumitrache S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dr. Ileana Dumitrache S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dr. Ileana Dumitrache S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dr. Ileana Dumitrache S.r.l. - CUI 35533081

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 1.213 755 3.711 3.709 2.523 1.445 926 7.031
Current Assets - - 6.898 28.063 27.748 54.344 51.016 49.108 62.877 75.143
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 3.275 3.267 5.735 7.116 8.051 7.684 47.793 64.687
Cash - - 3.623 24.796 22.012 47.228 42.965 41.424 15.084 10.456
Shareholders Funds - - 7.348 27.697 29.296 55.294 51.630 48.590 61.605 80.175
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 764 1.121 2.163 2.758 1.909 1.963 2.198 1.999
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 75.143 euro in 2023 which includes Inventories of 0 euro, Receivables of 64.687 euro and cash availability of 10.456 euro.
The company's Equity was valued at 80.175 euro, while total Liabilities amounted to 1.999 euro. Equity increased by 18.758 euro, from 61.605 euro in 2022, to 80.175 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dr. Ileana Dumitrache S.r.l.

Comments - Dr. Ileana Dumitrache S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.